학술논문

Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date.
Document Type
Article
Source
Cancer Management & Research; Sep2023, Vol. 15, p1025-1031, 7p
Subject
CHOLANGIOCARCINOMA
CLINICAL trials
ACUTE myeloid leukemia
ISOCITRATE dehydrogenase
BILIARY tract cancer
Language
ISSN
11791322
Abstract
Copyright of Cancer Management & Research is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)